Njoku DB, Kliegman RMAtypical extrapulmonary presentations of severe RSV infection requiring intensive care. Clin Pediatr.1993;32:455-460.
2.
La Via WV, Grant SW, Stutman HR, Marks MIClinical profile of pediatric patients hospitalized with respiratory syncytial virus infection. Clin Pediatr.1993 ;32:450-454.
3.
Dagan R., Hall C., Powell K., Menegus M.Epidemiology and laboratory diagnosis of infection with viral and bacterial pathogens in infants hospitalized for suspected sepsis. J Pediatr.1989;115: 351-356.
4.
Navas L., Wang E., de Carvalho V., Robinson J.Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J Pediatr.1992; 121:348-354.
5.
Committee on Infectious Diseases, American Academy of Pediatrics.Ribavirin therapy of respiratory syncytial virus. Red Book.1991;22:581-587.
6.
Englund J., Piedra PA, Jefferson LS, et al. High-dose, short-duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection. J Pediatr.1990;117:313-320.
7.
La Via WV, Marks MI, Stutman HRRespiratory syncytial virus puzzle: clinical features, pathophysiology, treatment and prevention. J Pediatr.1992; 121:503-510.
